1
Few prospective risk prediction models exist for advanced neoplasia (AN) in true average-risk individuals.
2
The principal outcome from the analysis was the cost per additional advanced neoplasia (AN) detected.
3
Factors associated with presence of advanced neoplasia were total number of polyps and presence of right-sided lesions.
4
Overall, few studies reported metachronous advanced neoplasia and no studies evaluated whether routine surveillance colonoscopy decreases risk of CRC.
5
Relative risks for advanced neoplasia within 5.5 years were calculated.
6
Patients with three or more biopsies demonstrating LGD at a single colonoscopy were at increased risk for progression to advanced neoplasia.
7
We conducted a prospective study to measure incidence of advanced neoplasia in patients within 5.5 years of screening colonoscopy.
8
We hypothesised that the risks for metachronous advanced neoplasia (AN) among patients with low-risk adenomas differ based on clinical factors distinct from those currently used.
9
Conclusion Advanced neoplasia was found to develop infrequently after detection of LGD in patients undergoing endoscopic surveillance for IBD.